Hannah A. Valantine

Hannah A. Valantine's AcademicInfluence.com Rankings

Hannah A. Valantine

Philosophy

#9176

World Rank

#12696

Historical Rank

Logic

#6166

World Rank

#7654

Historical Rank

philosophy Degrees

Hannah A. Valantine

Biology

#12551

World Rank

#16034

Historical Rank

Molecular Biology

#2051

World Rank

#2083

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Hannah A. Valantine Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hannah A. Valantine's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. (1998) (591)
Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. (1989) (480)
Intracoronary Ultrasound in Cardiac Transplant Recipients: In Vivo Evidence of “Angiographically Silent” Intimal Thickening (1991) (477)
Gene-expression profiling for rejection surveillance after cardiac transplantation. (2010) (418)
Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. (2005) (383)
Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection (2014) (377)
Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy (2013) (361)
Topic choice contributes to the lower rate of NIH awards to African-American/black scientists (2019) (319)
Universal noninvasive detection of solid organ transplant rejection (2011) (316)
Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. (1999) (287)
Cardiac allograft vasculopathy after heart transplantation: risk factors and management. (2004) (259)
National Institutes of Health addresses the science of diversity (2015) (251)
Noninvasive monitoring of infection and rejection after lung transplantation (2015) (249)
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. (2005) (227)
Reducing Implicit Gender Leadership Bias in Academic Medicine With an Educational Intervention (2016) (214)
Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens. (1989) (201)
Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. (1995) (187)
Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant “atheroma” (2003) (179)
Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group. (1995) (160)
Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. (1995) (159)
Coronary heart disease in African Americans. (2001) (156)
Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. (1996) (155)
Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. (1992) (152)
Wound Healing Complications with De Novo Sirolimus Versus Mycophenolate Mofetil‐Based Regimen in Cardiac Transplant Recipients (2006) (150)
Cytomegalovirus Infection Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine in Transplant Arteriosclerosis (2004) (150)
Acute Rejection and Cardiac Allograft Vascular Disease Is Reduced by Suppression of Subclinical Cytomegalovirus Infection (2006) (149)
Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. (1997) (146)
IMPACT OF CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN ON OUTCOME AFTER CARDIOTHORACIC TRANSPLANTATION: A Comparative Study of Combined Prophylaxis with CMV Hyperimmune Globulin Plus Ganciclovir Versus Ganciclovir Alone (2001) (144)
Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma (2015) (141)
Metabolic Abnormalities Characteristic of Dysmetabolic Syndrome Predict the Development of Transplant Coronary Artery Disease: A Prospective Study (2001) (138)
A hemodynamic and Doppler echocardiographic study of ventricular function in long-term cardiac allograft recipients. Etiology and prognosis of restrictive-constrictive physiology. (1989) (138)
Acute myocardial infarction in cardiac transplant recipients. (1989) (122)
Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection. (1987) (108)
Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. (1991) (107)
Molecular testing in the management of cardiac transplant recipients: initial clinical experience. (2006) (106)
Serial measurement of integrated ultrasonic backscatter in human cardiac allografts for the recognition of acute rejection. (1990) (105)
T-Cell Immunity to Subclinical Cytomegalovirus Infection Reduces Cardiac Allograft Disease (2006) (105)
Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. (1991) (103)
Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. (1994) (102)
The Role of Viruses in Cardiac Allograft Vasculopathy (2004) (102)
Mycophenolate Mofetil Reduces Intimal Thickness by Intravascular Ultrasound After Heart Transplant: Reanalysis of the Multicenter Trial (2006) (100)
Severe tricuspid regurgitation after heart transplantation. (2001) (97)
Cytomegalovirus-associated allograft rejection in heart transplant patients (2007) (89)
Differentially Expressed RNA from Public Microarray Data Identifies Serum Protein Biomarkers for Cross-Organ Transplant Rejection and Other Conditions (2010) (87)
Cardiac sarcoidosis: response to steroids and transplantation. (1987) (86)
Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation. (2008) (85)
Detection and treatment of coronary artery disease in liver transplant candidates (2001) (84)
Sensitivity and specificity of diastolic indexes for rejection surveillance: temporal correlation with endomyocardial biopsy. (1991) (79)
From the NIH: A Systems Approach to Increasing the Diversity of the Biomedical Research Workforce (2016) (79)
Prevention of Post‐transplant Cardiovascular Disease – Report and Recommendations of an Ad Hoc Group 1 (2002) (77)
Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study. (2006) (77)
Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors. (1996) (75)
Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation. (1995) (72)
Left ventricular diastolic function. Doppler echocardiographic changes soon after cardiac transplantation. (1990) (71)
Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. (2004) (71)
Nitroglycerin‐Induced Coronary Vasodilation in Cardiac Transplant Recipients: Evaluation With In Vivo Intracoronary Ultrasound (1992) (70)
Cell-Free DNA to Detect Heart Allograft Acute Rejection. (2021) (69)
Changing the culture of academic medicine to eliminate the gender leadership gap: 50/50 by 2020. (2013) (68)
Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation. (1999) (66)
The Gender Gap in Academic Medicine: Comparing Results From a Multifaceted Intervention for Stanford Faculty to Peer and National Cohorts (2014) (66)
Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation (2019) (66)
An Integrated Career Coaching and Time-Banking System Promoting Flexibility, Wellness, and Success: A Pilot Program at Stanford University School of Medicine (2018) (63)
Effect of cyclosporine on plasma endothelin levels in humans after cardiac transplantation. (1991) (63)
Metabolic risk factors for atherosclerosis in heart transplant recipients. (1994) (62)
Feasibility of serial intracoronary ultrasound imaging for assessment of progression of intimal proliferation in cardiac transplant recipients. (1994) (62)
Invasive Assessment of Coronary Physiology Predicts Late Mortality After Heart Transplantation (2016) (62)
Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis. (2018) (61)
Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis. (1993) (61)
Frequency of familial nature of dilated cardiomyopathy and usefulness of cardiac transplantation in this subset. (1989) (60)
Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy. (2007) (60)
Influence of recipient atrial contraction on left ventricular filling dynamics of the transplanted heart assessed by Doppler echocardiography. (1987) (60)
De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans (2019) (60)
Decisions, decisions: how program diversity influences residency program choice. (2011) (59)
Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound. Sandoz/CVIS Investigators. (1995) (58)
Women in Academic Medicine: Measuring Stereotype Threat Among Junior Faculty. (2016) (57)
Diabetes and dyslipidemia. A new model for transplant coronary artery disease. (1998) (57)
Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of a multicenter survey. (1990) (56)
The SIRPα–CD47 immune checkpoint in NK cells (2021) (55)
Calcineurin Inhibitors and Post-Transplant Hyperlipidaemias (2001) (54)
Changes in coronary anatomy and physiology after heart transplantation. (2007) (53)
Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype (2017) (52)
Neoral use in the cardiac transplant recipient. (2000) (51)
The impact of brain death on survival after heart transplantation: time is of the essence (2003) (51)
Role of lipids in allograft vascular disease: a multicenter study of intimal thickening detected by intravascular ultrasound. (1995) (50)
Exercise echocardiography in heart transplant recipients: a comparison with angiography and intracoronary ultrasonography. (1994) (50)
Outcome in Cardiac Recipients of Donor Hearts With Increased Left Ventricular Wall Thickness (2007) (50)
Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors. (2005) (49)
Changes in Coronary Arterial Dimensions Early After Cardiac Transplantation (2007) (48)
Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial. (2007) (48)
Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation. (2017) (47)
Everolimus (certican) in heart transplantation: optimizing renal function through minimizing cyclosporine exposure. (2005) (47)
Increasing pericardial effusion in cardiac transplant recipients. (1989) (46)
Glucose intolerance, as reflected by hemoglobin A1c level, is associated with the incidence and severity of transplant coronary artery disease. (2004) (46)
Changing trends in infectious disease in heart transplantation. (2010) (46)
Intracoronary ultrasound imaging in heart transplant recipients: the Stanford experience. (1992) (46)
Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient: a case of mistaken identity. (1998) (45)
Cardiac transplantation in patients with preexisting neoplastic diseases. (1990) (45)
Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation. (1992) (43)
Induction Therapy for Pediatric and Adult Heart Transplantation: Comparison Between OKT3 and Daclizumab (2005) (42)
Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology. (2007) (42)
From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation. (2005) (41)
Twenty‐Year Survivors of Heart Transplantation at Stanford University (2008) (40)
Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation. (2017) (40)
Cardiac allograft vascular disease. Relationship to microvascular cell surface markers and inflammatory cell phenotypes on endomyocardial biopsy. (1995) (40)
Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation. (1999) (39)
Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation. (2008) (34)
Volume-mediated pulmonary responses in liver transplant candidates. (1996) (33)
Prevention and treatment of cytomegalovirus disease in thoracic organ transplant patients: evidence for a beneficial effect of hyperimmune globulin. (1995) (33)
Identification and Classification of Acute Cardiac Rejection by Intragraft Transcriptional Profiling (2011) (32)
Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. (1995) (31)
Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients (2014) (31)
Transdisciplinary translational science and the case of preterm birth (2012) (29)
Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life. (1997) (29)
Frequent Occult Infection with Cytomegalovirus in Cardiac Transplant Recipients despite Antiviral Prophylaxis (2007) (29)
Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial. (2005) (28)
Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection. (2009) (28)
Role of CMV in transplant coronary artery disease and survival after heart transplantation. (1999) (28)
Doppler echocardiographic indices of diastolic function as markers of acute cardiac rejection. (1987) (28)
Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. (1997) (27)
Proliferation signal inhibitors and post‐transplant malignancies in heart transplantation: practical clinical management questions (2011) (27)
The relationship of granzyme A and perforin expression to cardiac allograft rejection and dysfunction. (1995) (27)
Identification of Common Blood Gene Signatures for the Diagnosis of Renal and Cardiac Acute Allograft Rejection (2013) (27)
Early Doppler echocardiographic dysfunction is associated with an increased mortality after orthotopic cardiac transplantation. (1996) (26)
Cytokine gene expression in human cardiac allograft recipients. (1994) (26)
Designing a physician leadership development program based on effective models of physician education (2017) (26)
Recent advances in cardiac transplantation. (1995) (26)
Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation. (2015) (26)
Detection of early atherosclerosis with radiolabeled monocyte chemoattractant protein-1 in prediabeteic Zucker rats (2001) (24)
Circulating cell-free DNA as a biomarker of tissue injury: Assessment in a cardiac xenotransplantation model. (2018) (24)
Importance of decreased heart rate in predicting transplant coronary artery disease. (1997) (24)
Distribution and morphologic features of coronary artery disease in cardiac allografts: an intracoronary ultrasound study. (1995) (24)
New developments in immunosuppressive therapy for heart transplantation (2009) (24)
Impact of Donor-Transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy: New Findings by Three-Dimensional Intravascular Ultrasound Analysis (2011) (24)
Asymmetric Dimethylarginine and Cardiac Allograft Vasculopathy Progression: Modulation by Sirolimus (2008) (24)
Coronary Endothelial Dysfunction and the Index of Microcirculatory Resistance as a Marker of Subsequent Development of Cardiac Allograft Vasculopathy. (2017) (23)
The impact of cyclosporine dose and level on the development and progression of allograft coronary disease. Sandoz/CVIS Investigators. (1995) (23)
Changes in cardiac morphology and function following single-lung transplantation. (1991) (23)
Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation. (2007) (22)
Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation. (2005) (22)
Recurrence of amyloid in a cardiac allograft four months after transplantation. (1989) (21)
Correlation of donor characteristics with transplant coronary artery disease as assessed by intracoronary ultrasound and coronary angiography. (1995) (21)
Monitoring Pharmacologically Induced Immunosuppression by Immune Repertoire Sequencing to Detect Acute Allograft Rejection in Heart Transplant Patients: A Proof-of-Concept Diagnostic Accuracy Study (2015) (21)
Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy. (2016) (20)
Validation of a screening protocol for identifying low‐risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation (2006) (20)
Variability of Doppler echocardiographic indexes of left ventricular filling in transplant recipients and in normal subjects. (1990) (20)
Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era. (2003) (20)
Mycophenolic acid concentrations in long‐term heart transplant patients: relationship with calcineurin antagonists and acute rejection (2002) (19)
Transplant Coronary Artery Disease: A Novel Model Independent of Cellular Alloimmune Response (2001) (19)
HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: evidence for antigen-independent mechanisms? (1997) (18)
Gene Expression Profiling to Study Racial Differences after Heart Transplantation (2015) (18)
Impact of cyclosporine dose on long-term outcome after heart transplantation. (1994) (17)
Increased rejection in gender-mismatched grafts: amelioration by triple therapy. (1991) (16)
The role of complement‐fixing donor‐specific antibodies identified by a C1q assay after heart transplantation (2017) (16)
Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients. (2013) (16)
Applications of genetic-epigenetic tissue mapping for plasma DNA in prenatal testing, transplantation and oncology (2021) (15)
NIH's scientific approach to inclusive excellence (2020) (14)
Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy. (2006) (14)
Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: a single-center experience. (2003) (14)
Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets. (2007) (13)
Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients. (2014) (13)
Safety and efficacy of everolimus (RAD) as part of a triple immunosuppressive regimen in de novo cardiac transplant recipients: six-month analysis (2002) (13)
Further analysis of the intravascular ultrasound data from the randomized mycophenolate mofetil (MMF) trial in heart transplant recipients (2004) (12)
Where Are We in Bridging the Gender Leadership Gap in Academic Medicine? (2020) (12)
Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection. (2002) (12)
Intracoronary ultrasound evaluation of intimal thickening in cardiac transplant recipients: Correlation with clinical characteristics (1991) (12)
Transplant Coronary Disease (1991) (12)
Women in science: Women’s work (2013) (11)
Three-Year Allograft Vasculopathy Results of the Multicenter Heart Transplant Mycophenolate Mofetil Randomized Trial (1999) (10)
Detection of accelerated graft atherosclerosis importance of hemodynamic response to exercise (1988) (10)
Early invasive assessment of the coronary microcirculation predicts subsequent acute rejection after heart transplantation. (2019) (10)
Survivors more than 10 years after heart transplantation in the cyclosporine era (2002) (10)
Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis. (2006) (10)
Pulmonary nocardiosis in a heart transplant patient: case report and review of the literature. (2007) (9)
Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury. (2021) (9)
Long-term management and results in heart transplant recipients. (1990) (9)
Individualizing immunosuppression for heart transplantation: strategies for the next decade. (1997) (8)
Prognosis of patients with significant angiographically diagnosed cardiac allograft coronary disease (2002) (8)
Cytokines as potential mediators of acute allograft diastolic dysfunction in cyclosporine-treated patients: a pilot study using in situ hybridization. (1994) (8)
Towards Equity in Health: Researchers Take Stock (2016) (8)
Peripheral Blood Leukocyte Counts in Cytomegalovirus Infected Heart Transplant Patients: Impact of Acute Disease Versus Subclinical Infection (2006) (7)
Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease (2001) (7)
Cardiac function after domino-donor heart transplantation. (1992) (7)
Reversal of diabetes-induced rat graft transplant coronary artery disease by metformin. (2002) (7)
Academic couples: implications for medical school faculty recruitment and retention. (2011) (7)
Medical Faculty Development: A Modern-Day Odyssey (2011) (7)
Association of Endothelin-1 With Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart Transplantation. (2019) (7)
NIH progress toward inclusive excellence (2020) (7)
50 Years to Gender Parity: Can STEM Afford to Wait?: A Cardiologist and NIH Chief Officer of Scientific Workforce Diversity Reflects on What It Will Take to Keep Women in Biomedicine (2017) (6)
Does late switch to mycophenolate mofetil affect development of transplant coronary artery disease (2002) (5)
Pulled in Too Many Directions: The Causes and Consequences of Work-Work Conflict (2018) (5)
Long-term prognostic value of invasive and non-invasive measures early after heart transplantation. (2018) (5)
Higher levels of allograft injury in black patients early after heart transplantation. (2021) (5)
Multi-center intravascular ultrasound validation study among heart transplant recipients: outcomes after 5 years (2004) (5)
Rejection surveillance by Doppler echocardiography. (1993) (5)
Transcriptomics in transplantation: More than just biomarkers of allograft rejection (2020) (5)
Cytomegalovirus infection and allograft injury (2001) (5)
NIH's Essential 21st-Century Research Challenge: Enhancing Scientific Workforce Diversity. (2016) (4)
Teaching Corporate in College (2014) (4)
Conversion of cyclosporine to tacrolimus in heart transplant patients: a single center experience (2002) (4)
469 Correlation of Cytomegalovirus (CMV) Serologic Status of Heart Transplant Recipients to Gene-Expression Profiling Scores and Clinical Outcomes: Results from the IMAGE Multicenter Study (2012) (4)
How to Recognize and Address Unconscious Bias (2020) (4)
The effect of negative remodeling on fractional flow reserve after cardiac transplantation. (2017) (4)
Circulating microRNAs in cellular and antibody-mediated heart transplant rejection. (2022) (4)
Mild cardiac allograft coronary disease does not change the prognosis of patients after heart transplantation (2002) (3)
Workforce Diversity and Capacity Building to Address Health Disparities (2021) (3)
Non-Invasive Monitoring of Infection and Rejection After Lung Transplantation (2015) (3)
PLASMA CELL-FREE DNA AS A NOVEL MARKER OF DISEASE SEVERITY IN PULMONARY ARTERIAL HYPERTENSION (2019) (3)
MYCOPHENOLATE MOFETIL IS ASSOCIATED WITH LESS CARDIAC TRANSPLANT REJECTION THAN AZATHIOPRINE IN PATIENTS WITH RECURRENT REJECTIONS (1999) (3)
Genomic Research Alliance for Transplantation (GRAfT): A Model for Long Term Transplant Studies in Thoracic Organ Transplantation (2016) (3)
Precision of a Novel High-Definition 60MHz IVUS in Quantitative Measurement: Comparison with Conventional 40MHz IVUS and Optical Coherence Tomography (2014) (3)
Everyday Heroism: Maintaining Organizational Cultures of Wellness and Inclusive Excellence Amid Simultaneous Pandemics (2020) (3)
Racial Disparities after Heart Transplant: Evidence from IMAGE (2013) (3)
Hyperhomocysteinemia Is Common In Heart Transplant Patients But Is Not Correlated With Transplant Coronary Artery Disease (1999) (3)
Determinants of Lumen Loss Between Years 1 and 2 After Cardiac Transplantation (2007) (2)
Cytomegalovirus and heart transplant atherosclerosis: a likely guilt hidden by weak proofs. (2004) (2)
Cytomegalovirus and Development of Cardiac Allograft Vasculopathy: Evidences and Therapeutic Implications (2010) (2)
Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After HeartTransplantation (2016) (2)
Circulating Cell-Free DNA Is a Non-Invasive Marker of Heart Transplant Rejection (2014) (2)
(148) - Early Graft Injury Measured by Donor-Derived Cell-Free DNA Predicts Early Mortality in Lung Transplant Recipients (2017) (2)
157: Early detection of cardiac allograft vasculopathy through gene expression profiling – insights of the CARGO study (2006) (2)
Economic Impact of Monitoring Heart Transplant Recipients With Gene Expression Profiling to Detect Rejection: an IMAGE Analysis. (2010) (2)
Resolution of restrictive physiology following cardiac allograft rejection: An indicator of resolved rejection (1990) (2)
Ending Sexual Harassment in Science: Designing and Administering a Survey That Can Lead to an Improved Organizational Climate (2021) (2)
Elevated Donor-Derived Cell-Free DNA (ddcfDNA) as an Early Risk Factor for the Development and Persistence of De Novo Donor Specific HLA Antibody (2018) (2)
A giant leap for womankind (2019) (2)
Policy: NIH push to stop sexual harassment (2016) (2)
Impact of Asymmetric Dimethylarginine on Coronary Physiology Early After Heart Transplantation. (2017) (2)
(1219) - Association Between LVAD and Cardiac Allograft Injury Following Heart Transplantation as Assessed by Cell-Free DNA (2017) (2)
Everolimus is associated with a reduced incidence of CMV infection in heart transplantation (2003) (2)
Elevated cell‐free DNA in respiratory viral infection and associated lung allograft dysfunction (2022) (2)
Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension (2022) (2)
[Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome]. (2007) (2)
Science Has a Gender Problem. (2016) (2)
Validation of Donor-derived Cell-free DNA to Detect Heart-transplant Rejection (2018) (2)
Donor Derived Cell Free DNA is Elevated With Pathogens That are Risk Factors For Chronic Lung Allograft Dysfunction (2018) (1)
Genetic-epigenetic tissue mapping for plasma DNA: applications in prenatal testing, transplantation and oncology (2020) (1)
Immune mediators of acute cardiac allograft dysfunction (1991) (1)
Preferential involvement of larger vessels in a rat model of diabetes-induced graft vasculopathy. (2002) (1)
Abstract 2411: The Importance of Right Ventricular Dysfunction in patients with Hemodynamically Compromising Rejection (2008) (1)
Donor-derived mitochondrial DNA variant peptides elicit allo-specific immune response in transplant patients (2020) (1)
ANGIOTENSIN-CONVERTING ENZYME INHIBITION EARLY AFTER CARDIAC TRANSPLANTATION: A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING RAMIPRIL VERSUS PLACEBO (2016) (1)
Cardiac Allograft Injury in Patients of African Ancestry: Trends of Donor-Derived Cell-Free DNA Based on Genetic Ancestry (2021) (1)
Is the New ISHLT Criteria for Pulmonary Antibody-mediated Rejection Also a Severity Indicator? (2018) (1)
Role of dd-cfDNA in Predicting Early Post-operative Course in Lung Transplant Recipients (2018) (1)
813-1 Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients (2004) (1)
Utility of Gene Expression Profiling Test Score Stability To Predict Future Clinical Events in Heart Transplant Recipients (2013) (1)
162: Sirolimus Use in Heart Transplant Recipients Is Associated with a High Incidence of Adverse Reactions Requiring Drug Discontinuation (2008) (1)
Frequent Occult Infection with Cytomegalovirus in Cardiac Transplant Recipients despite Antiviral Prophylaxis (2008) (1)
20-year survivors of heart transplantation at Stanford University (2009) (1)
Magnetic resonance imaging-derived parameter of portal flow predicts volume-mediated pulmonary hypertension in liver transplantation candidates. (1995) (1)
Cardiac transplantation (2004) (1)
Sirolimus Adverse Event Profile in a Non-Clinical Trial Cohort of Heart Transplantation Patients (2020) (1)
Predicting Risk of Early Readmission in Lung Transplant Recipients Using dd-cfDNA (2018) (1)
Allograft Injury and Outcomes in African American Lung Transplant Recipients. (2020) (1)
Variable Cell-free DNA Characteristics With Different Acute Rejection Phenotypes (2018) (1)
Advancing the Progress of Mentoring for Diversity in AIDS Research: Warming the Mentoring Climate (2016) (1)
Antibody-mediated Rejection: Should We Wait for Clinical Diagnosis? (2018) (1)
162: Inhibition of cardiac allograft vasculopathy by sirolimus and mycofenolate: Asymmetric dimethyl arginine as a potential therapeutic target (2006) (1)
Circulating microRNA Biomarkers in Cellular and Antibody-Mediated Heart Transplant Rejection (2022) (1)
556 Heart Transplants Are Genome Transplants: Universal Noninvasive Detection of Solid Organ Transplant Rejection (2011) (1)
Impact of prophylactic immediate post-transplant genciclovir on development of transplant atherosclerosis: A randomized placebo-controlled study (1996) (1)
Clinically-unrecognized Allograft Injury is Common After Lung Transplantion (2018) (1)
The Association between Donor-Recipient Race Matching and Survival Following Lung Transplantation Differs Based on Recipient Race (2016) (0)
Cell-Free DNA to Monitor Immunosuppression Adequacy in Lung Transplantation (2021) (0)
Doppler and M-Mode Echocardiographic Assessment of Left Ventricular Function during Acute Cardiac Allograft Rejection (1987) (0)
Circulating cell-free DNA ( cfDNA ) is emerging as a powerful monitoring tool in cancer , pregnancy and organ transplantation (2015) (0)
Increasing Pericardial Effusion (2005) (0)
(511) - Pre-Transplant Donor-Recipient Characteristics and the Relationship to Early Cardiac Allograft Injury Measured by Cell-Free DNA (2017) (0)
78 Do Longitudinal Stable Lower AlloMap® Scores Portend Better Outcomes after Heart Transplantation? (2011) (0)
Abstract 2314: Altered Metabolism of Asymetric Dimethylarginine (ADMA) is Associated with Endothelial Dysfunction and Negative Arterial Remodelling After Heart Transplantation (2007) (0)
(1145) - Mitochondria Energetics Is Significantly Altered During Acute Cellular Rejection in a Rat Transplantation Model (2017) (0)
Can We Predict Rejection Early After Heart Transplantation? (2021) (0)
Impact of AMR Treatment: Responders vs Non-Responders Characteristics (2021) (0)
Usefulness of Asymmetric Dimethylarginine to Predict Outcomes After Heart Transplantation. (2018) (0)
Abstract 2576: Impact of Donor-transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy; New Findings by 3-D IVUS (2006) (0)
733-4 Induction of Inducible Nitric Oxide Synthase (iNOS) mRNA and Protein in the Human Cardiac Allograft is Associated with Increased Myocardial cGMP Levels and Echocardiographic LV Dysfunction (1995) (0)
Association between Pretransplant Antibody against Angiotensin II Type 1 Receptor and Posttransplant Allograft Injury. (2020) (0)
OR20 Nhlbi-sponsored prospective study to validate the use of donor-derived cell-free DNA to detect lung-transplant rejection - interim results (2019) (0)
IMPACT OF ENDOTHELIN-1 ON CARDIAC ALLOGRAFT VASCULOPATHY, LATE MORTALITY AND RE-TRANSPLANTATION FOLLOWING HEART TRANSPLANTATION (2018) (0)
129 Incidence and Predictors of Late Rejection after Cardiac Transplantation (2011) (0)
Cell-Free DNA Enhances Pathologist Interrater Reliability at the Assessment of Acute Rejection on Endomyocardial Biopsy, on Behalf of the GRAfT Investigators (2023) (0)
IMPROVEMENT IN RIGHT HEART FAILURE AFTER TRICUSPID VALVE REPLACEMENT IN CARDIAC TRANSPLANT PATIENTS (1999) (0)
GLUCOSE INTOLERANCE AS REFLECTED BY HEMOGLOBIN A1C IS SIGNIFICANTLY ASSOCIATED WITH A HIGH INCIDENCE OF TRANSPLANT CORONARY ARTERY DISEASE (1999) (0)
342 Non-Stenotic Coronary Vasculopathy Is Associated with Reduced Survival after Heart Transplantation (2012) (0)
Transplant Arteriopathy: Role of Nitric Oxide Synthase (2006) (0)
Applying Genomics to Unravel Health Disparities in Organ Transplantation: Paul I. Terasaki State-of-the-art Lecture; American Transplant Congress 2021. (2022) (0)
Characteristics of Urine Cell-Free DNA in Heart and Lung Transplant (2019) (0)
Tc-99m ISONITRILE SCINTIGRAPHY OFFERS AN IMPROVED NONINVASIVE METHOD FOR ASSESSING SIGNIFICANT TRANSPLANT CORONARY ARTERY VASCULOPATHY (1992) (0)
98: Comparison of Gene Expression Profiling and Endomyocardial Biopsy for Surveillance of Acute Cardiac Cellular Rejection: Results from the IMAGE Trial (2010) (0)
olecular Testing in the Management of Cardiac Transplant ecipients : Initial Clinical Experience (2006) (0)
Abstract 16130: Early Invasive Assessment of the Coronary Microcirculation Predicts Subsequent Acute Rejection After Heart Transplantation (2016) (0)
Proceedings of a symposium on individualizing immunosuppression : strategies for the next decade, October 25-26, 1996, Tucson, Arizona (1997) (0)
Is ultrasound of clinical value in the management of heart transplant patients (1993) (0)
Early and Late Pulmonary AMR Show Distinct Profiles; Clinical and Epigenetic Analyses. (2020) (0)
Editorial: Equity in Transplantation: A Commitment for Progress in Troubled Times (2022) (0)
Appropriate Intravascular Ultrasound Measurement Intervals for Assessment of Cardiac Allograft Vasculopathy after Heart Transplantation (2014) (0)
Cytomegalovirus burden and progressive severity of cardiac allograft vasculopathy (2004) (0)
Reproducibility of Genomic Data Using Standards-Cell Free DNA to Monitor Rejection after Heart Transplantation (2016) (0)
Abstract 14016: The Development of De Novo Anti-hla Antibodies after Heart Transplant is Related to the Development of Rejection Depending of Their Complement Fixing Capability (2012) (0)
(1228) - Genomic Research Alliance for Transplantation (GRAfT) A Unique Cohort to Address Age, Sex and Race in Heart Transplants (2017) (0)
The endogenous nitric oxide synthase inhibitor Asymmetric Dimethylarginine (ADMA) predicts cardiac allograft vasculopathy progression (2007) (0)
Lung Transplant Recipients with Severe Primary Graft Dysfunction Requiring ECMO Had Similar Donor-Derived Cell-Free DNA Levels and Lung Function as Matched Controls. (2020) (0)
End-stage renal failure and kidney transplantation in heart transplant recipients (2002) (0)
Author response: Applications of genetic-epigenetic tissue mapping for plasma DNA in prenatal testing, transplantation and oncology (2021) (0)
Non-stenotic coronary vasculopathy is associated with reduced survival after heart transplantation (2013) (0)
Abstract 10765: Plasma Cell-Free DNA Predicts Survival and Maps Tissue-Specific Sources of Injury in Pulmonary Arterial Hypertension (2021) (0)
Abstract 2959: Granulocyte-Colony Stimulating Factor Therapy is Associated with Reduced Incidence of Acute Rejections and Allograft Vasculopathy in Heart Transplant Recipients (2008) (0)
Cell-Free DNA to Distinguish High Risk Donor Specific Antibodies in Heart Transplantation (2022) (0)
238: Progression of mild rejection: Impact on new ISHLT classification (2007) (0)
Response by Shah et al to Letter Regarding Article, "Cell-Free DNA to Detect Heart Allograft Acute Rejection". (2021) (0)
TCT-360 Appropriate Intravascular Ultrasound Measurement Intervals for Assessment of Cardiac Allograft Vasculopathy after Heart Transplantation (2014) (0)
288: 20-Year Survivors of Heart Transplantation at Stanford University (2009) (0)
Influence of brain death on survival after heart transplantation - time is of the essence (2002) (0)
TACROLIMUS IS ASSOCIATED WITH IMPROVED VENTRICULAR SYSTOLIC AND DIASTOLIC CARDIAC ALLOGRAFT FUNCTION: ? DIRECT EFFECT ON MYOCYTE FUNCTION.: Abstract# 699 (2000) (0)
INVASIVE CORONARY PHYSIOLOGY AT ONE YEAR PREDICTS LATE MORTALITY AFTER HEART TRANSPLANTATION (2015) (0)
Aggressive anti-cytomegalovirus prophylaxis and acute rejection in high risk patients: Beat the virus and prevent the rejection (2005) (0)
185 Impact of Donor and Recipient Sex on Survival and Acute Rejection after Heart Transplantation: Analysis of the ISHLT Database (2011) (0)
VOLUMETRIC VERSUS PLANAR INTRAVASCULAR ULTRASOUND ANALYSIS TO ASSESS SEVERITY OF CARDIAC ALLOGRAFT VASCULOPATHY (2014) (0)
Role of cytomegalovirus and asymmetric dimethylarginine in the derangement of nitric oxide synthase in cardiac allograft recipients (2003) (0)
EARLY CORONARY ENDOTHELIAL DYSFUNCTION PREDICTS ACCELERATED PLAQUE PROGRESSION 1 YEAR AFTER CARDIAC TRANSPLANTATION: SERIAL VOLUMETRIC EVALUATION BY INTRAVASCULAR ULTRASOUND (2016) (0)
Pulmonary Antibody-Mediated Rejection (AMR) Accelerates Aging-Evidence from Whole Genome DNA Methylation Sequencing (2019) (0)
Factors associated with long-term survival after heart transplantation in the cyclosporine era (2002) (0)
189: Relationship between insulin resistance features and progression of cardiac allograft vasculopathy (2007) (0)
Echocardiographic Diagnosis of Acute Allograft Rejection (2001) (0)
Relation between renal function and neointimal tissue characteristics after drug-eluting stent implantation: virtual histology-intravascular ultrasound analysis (2014) (0)
Abstract 15798: MicroRNA Profiles in Cardiac Transplantation Distinguish Antibody-Mediated and Cellular Rejection (2017) (0)
(478) – Relationship of Early Lung Allograft Injury as Measured by Cell Free DNA with Donor and Recipient Characteristics (2017) (0)
Mitochondrial DNA Mismatches in Thoracic Transplantation: Potential Triggers of Allograft Immunogenicity (2019) (0)
Feasibilit of Serial Intracoronary Ultrasound Imaging for Assessment of Progression of Intimal Proliferation in Cardiac Transplant Recipients (2005) (0)
Impact of prophylactic OKT3 on mild acute rejection of the cardiac allograft (1990) (0)
Cell-Free DNA Tissue Damage Mapping in Transplant Patients Infected with COVID-19 (2021) (0)
The Role of Echocardlography In the FoIIow‐Up of Orthotopic Heart Transplant Patients (1996) (0)
Increased Cell Free DNA Levels in African American Patients Early after Heart Transplantation. (2020) (0)
De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans (2019) (0)
Comparative Utility of Gene Expression Profiling Score Variability, Endomyocardial Biopsy, and Echocardiography to Predict Future Clinical Events in Heart Transplant Recipients (2014) (0)
TCT-818 Early Left Ventricular Dysfunction is Associated with Cardiac Allograft Vasculopathy and Late Mortality After Heart Transplantation. (2016) (0)
OR53 Post transplant monitoring to include donor derived cell free DNA (%ddcfDNA): Steps toward personalized medicine (2018) (0)
525 Prognostic Value of the ISHLT and DGK Working Formulations for Transplant Vasculopathy in Survival after Heart Transplantation (2011) (0)
Abstract 2965: QT Interval Prolongation during Severe Acute Rejection is Predictive of Sudden Cardiac Death in Heart Transplant Recipients (2008) (0)
Imaging Intravascular - IVUS (TCT-344 to TCT-364)TCT-351 Attenuated-Signal Plaque and Cardiac Allograft Vasculopathy: A Serial Volumetric IVUS Study of Heart Transplant Recipients (2014) (0)
Ventricular Function in Long-term Cardiac Allograft Recipients (2005) (0)
258: The importance of diabetes, biventricular failure and cellular infiltrates in hemodynamically compromising rejection (2007) (0)
SAFETY, TOLERABILITY, AND EFFICACY OF CYCLOSPORINE MICROEMULSION IN HEART TRANSPLANT RECIPIENTS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND COMPARISON WITH THE OIL-BASED FORMULATION OF CYCLOSPORINE—RESULTS AT 24 MONTHS AFTER TRANSPLANTATION1 (2001) (0)
De Novo Mutations in Mitochondrial DNA of iPSCs Produce Immunogenic Neoepitopes in Humans. (2020) (0)
To Treat or Not to Treat: DSA Positive Lung Transplant Recipients. (2020) (0)
Stereotype Threat Survey (2017) (0)
Novel Model To Assess Prognosis of Transplant Vasculopathy Following Cardiac Transplantation (2013) (0)
273: Prevention of subclinical CMV infection reduces cardiac allograft disease progression by positively affecting coronary remodeling (2006) (0)
A Pioneer in Transplantation Genomics, Inclusion, and Diversity: A Conversation With Hannah Valantine, MBBS, MD. (2021) (0)
Abstract 2575: Negative Remodeling is Primarily Responsible for Coronary Artery Lumen Loss Early After Cardiac Transplantation: Role of Cytomegalovirus (2006) (0)
Early Donor-Derived Cell-Free DNA Predicts Peak Allograft Function in Heart Transplant. (2020) (0)
HIGHER LEVELS OF ASYMMETRIC DIMETHYLARGININE ARE ASSOCIATED WITH LOWER FRACTIONAL FLOW RESERVE AFTER ORTHOTOPIC HEART TRANSPLANTATION (2016) (0)
Title Towards equity in health : researchers take stock (2016) (0)
Circulating Xenograft-Derived Cell-Free DNA as a Reliable Marker for Injury After Xenotransplantation (2017) (0)
Cardiac Allograft Vascular Disease (2020) (0)
119 Personalized Clinical Rejection Surveillance after Cardiac Transplantation by Longitudinal Gene Expression Profiling (2011) (0)
494: Changing Trends in Infectious Complications among Heart Transplant Recipients (2009) (0)
Impact of type 1 diabetes on microvascular vs. macrovascular involvement with TXCAD: is there a difference in models of the disease? (2001) (0)
Circulating, Cell-Free, MicroRNA Sequencing to Diagnose Cardiac Allograft Rejection and Distinguish Rejection Subtype (2019) (0)
Inflammatory Events Precede Development of De Novo DSA after Lung Transplantation (2019) (0)
Racial Differences in Immunosuppression and Lung Transplant Outcomes (2021) (0)
Cfcloud: A Cloud-Based Workflow for Cell-Free DNA Data Analysis (2020) (0)
Urine Cell-Free Donor-Derived DNA (ucfdDNA) after Heart Transplantation (2016) (0)
Dysregulated Circulating Proteins in Cellular and Antibody-Mediated Rejection, on Behalf of the Graft Investigators (2023) (0)
486: Does the presence of adiposity or the metabolic syndrome in transplant donor or recipient increase the progression of cardiac allograft vasculopathy? (2007) (0)
THE IMPACT OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ON ASYMMETRIC DIMETHYLARGININE IN ORTHOTOPIC HEART TRANSPLANTATION RECIPIENTS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (2016) (0)
468: Microvascular Dysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hannah A. Valantine?

Hannah A. Valantine is affiliated with the following schools:

Stanford University

Hannah A. Valantine's Academic­Influence.com Rankings

Why Is Hannah A. Valantine Influential?

Hannah A. Valantine's Published Works

Published Works

What Schools Are Affiliated With Hannah A. Valantine?

Hannah A. Valantine's AcademicInfluence.com Rankings